The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

“The FDA should not be authorizing the sale of any flavored tobacco products ... among the public figures who have embraced Zyn. Philip Morris has stated it does not employ online influencers ...

Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant ...

The Food and Drug Administration officially approved Thursday the sale of wildly popular Zyn nicotine pouches as a less ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...